Literature DB >> 7911573

Dehydroepiandrosterone is an anxiolytic in mice on the plus maze.

C L Melchior1, R F Ritzmann.   

Abstract

Dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) are neurosteroids that have been shown to interact with the GABA system. The present study examined the effects of these compounds in mice on motor activity and behavior in the elevated plus maze. Doses of 0.5 mg/kg and above of DHEA reduced motor activity. This effect was blocked by diazepam, RO15-1788, pentylenetetrazole (PTZ), and ethanol. Both DHEA and DHEAS showed anxiolytic activity in the plus maze test, with DHEA being effective over a very wide range of doses (5 micrograms/kg to 1.0 mg/kg). Both RO15-1788 and PTZ blocked the anxiolytic effect of DHEA, there was no interaction with diazepam, and ethanol enhanced the anxiolytic effect of DHEA. At 1.0 mg/kg, DHEAS blocked the anxiolytic effect of ethanol. These results support the hypothesis that neurosteroids could be involved in the termination of a stress response.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7911573     DOI: 10.1016/0091-3057(94)90140-6

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  19 in total

1.  Anxiolytic drug targets: beyond the usual suspects.

Authors:  Joshua A Gordon
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 2.  Neuroactive steroids and anxiety disorders.

Authors:  Jean-Michel Le Mellédo; Glen B Baker
Journal:  J Psychiatry Neurosci       Date:  2002-05       Impact factor: 6.186

3.  The non-benzodiazepine anxiolytic drug etifoxine causes a rapid, receptor-independent stimulation of neurosteroid biosynthesis.

Authors:  Jean Luc do Rego; David Vaudry; Hubert Vaudry
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

4.  Expression of P450c17 in the human fetal nervous system.

Authors:  Marcus D Schonemann; Marcus O Muench; Meng Kian Tee; Walter L Miller; Synthia H Mellon
Journal:  Endocrinology       Date:  2012-03-20       Impact factor: 4.736

Review 5.  A review of dehydroepiandrosterone (DHEA).

Authors:  C N Shealy
Journal:  Integr Physiol Behav Sci       Date:  1995 Sep-Dec

6.  Neuropsychopharmacological properties of neuroactive steroids in depression and anxiety disorders.

Authors:  Daniela Eser; Cornelius Schüle; Elena Romeo; Thomas C Baghai; Flavia di Michele; Augusto Pasini; Peter Zwanzger; Frank Padberg; Rainer Rupprecht
Journal:  Psychopharmacology (Berl)       Date:  2005-10-25       Impact factor: 4.530

7.  Cortisol and DHEA-S are associated with startle potentiation during aversive conditioning in humans.

Authors:  Christian Grillon; Daniel S Pine; Johanna M P Baas; Megan Lawley; Valerie Ellis; Dennis S Charney
Journal:  Psychopharmacology (Berl)       Date:  2005-07-29       Impact factor: 4.530

8.  Anxiety- and depressive-like responses and c-fos activity in preproenkephalin knockout mice: oversensitivity hypothesis of enkephalin deficit-induced posttraumatic stress disorder.

Authors:  Jen-Chuang Kung; Tsung-Chieh Chen; Bai-Chuang Shyu; Sigmund Hsiao; Andrew Chih Wei Huang
Journal:  J Biomed Sci       Date:  2010-04-21       Impact factor: 8.410

9.  DHEA enhances emotion regulation neurocircuits and modulates memory for emotional stimuli.

Authors:  Rebecca K Sripada; Christine E Marx; Anthony P King; Nirmala Rajaram; Sarah N Garfinkel; James L Abelson; Israel Liberzon
Journal:  Neuropsychopharmacology       Date:  2013-04-03       Impact factor: 7.853

Review 10.  Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS).

Authors:  Nicole Maninger; Owen M Wolkowitz; Victor I Reus; Elissa S Epel; Synthia H Mellon
Journal:  Front Neuroendocrinol       Date:  2008-12-03       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.